P

Pulsenmore Ltd
TASE:PULS

Watchlist Manager
Pulsenmore Ltd
TASE:PULS
Watchlist
Price: 300 ILS -8.09%
Market Cap: 149.8m ILS

Relative Value

The Relative Value of one PULS stock under the Base Case scenario is 50.95 ILS. Compared to the current market price of 300 ILS, Pulsenmore Ltd is Overvalued by 83%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PULS Relative Value
Base Case
50.95 ILS
Overvaluation 83%
Relative Value
Price
P
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
78
vs Industry
7
Median 3Y
25.7
Median 5Y
30
Industry
2.3
vs History
vs Industry
Median 3Y
-4.8
Median 5Y
-8.8
Industry
22.4
vs History
vs Industry
Median 3Y
-5.7
Median 5Y
-6.9
Industry
14.4
vs History
vs Industry
Median 3Y
-5.1
Median 5Y
-6.1
Industry
21.7
vs History
58
vs Industry
54
Median 3Y
2
Median 5Y
2.2
Industry
2.2
vs History
71
vs Industry
15
Median 3Y
15.9
Median 5Y
17.1
Industry
2.5
vs History
53
vs Industry
7
Median 3Y
36.4
Median 5Y
27.5
Industry
5.1
vs History
vs Industry
Median 3Y
-3.1
Median 5Y
-4.1
Industry
12
vs History
vs Industry
Median 3Y
-2.9
Median 5Y
-3.9
Industry
16.9
vs History
vs Industry
Median 3Y
-3.2
Median 5Y
-4.3
Industry
14.5
vs History
vs Industry
Median 3Y
-3.1
Median 5Y
-4.2
Industry
18.6
vs History
71
vs Industry
41
Median 3Y
4.2
Median 5Y
5.1
Industry
1.8

Multiples Across Competitors

PULS Competitors Multiples
Pulsenmore Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IL
Pulsenmore Ltd
TASE:PULS
149.8m ILS 16.1 -3.4 -2.2 -2
US
Abbott Laboratories
NYSE:ABT
217.7B USD 5 15.6 19.9 27.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
207.9B USD 21.6 75.7 58.1 70.8
US
Boston Scientific Corp
NYSE:BSX
142.9B USD 7.4 51.2 29.9 40.7
US
Stryker Corp
NYSE:SYK
136.3B USD 5.6 46.3 22.6 27.4
IE
Medtronic PLC
NYSE:MDT
125.3B USD 3.6 26.3 14.8 21.4
DE
Siemens Healthineers AG
XETRA:SHL
50.2B EUR 2.1 23.4 13.2 18.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
56.2B USD 13.5 54.7 39.3 43.5
US
Becton Dickinson and Co
NYSE:BDX
56.2B USD 2.6 33.5 12.4 21.1
US
Edwards Lifesciences Corp
NYSE:EW
50.2B USD 8.5 36.7 26.3 28.8
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
38.2B USD 1.9 17.2 12.9 15.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IL
P
Pulsenmore Ltd
TASE:PULS
Average EV/EBITDA: 24.9
Negative Multiple: -2.2
N/A N/A
US
Abbott Laboratories
NYSE:ABT
19.9
12%
1.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
58.1
26%
2.2
US
Boston Scientific Corp
NYSE:BSX
29.9
22%
1.4
US
Stryker Corp
NYSE:SYK
22.6
13%
1.7
IE
Medtronic PLC
NYSE:MDT
14.8
8%
1.9
DE
Siemens Healthineers AG
XETRA:SHL
13.2
11%
1.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
39.3
14%
2.8
US
Becton Dickinson and Co
NYSE:BDX
12.4
9%
1.4
US
Edwards Lifesciences Corp
NYSE:EW
26.3
13%
2
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
12.9
10%
1.3